Differences between process validation, exhibit and submission batches.

In the pharmaceutical industry, validation batches, exhibit batches, and submission batches serve specific roles in drug development and regulatory approval. Here’s a clear breakdown of the differences

1. Validation Batches • Purpose: To demonstrate that the manufacturing process is capable of consistently producing a product that meets predetermined quality standards. • Stage: Typically produced after process development but before commercial production. • Key Focus: • Process consistency and reproducibility • Equipment and process qualification • Must follow cGMP guidelines • Quantity: Usually three consecutive batches are produced for process validation. • Used for: Internal documentation, regulatory submissions (as evidence of process validation), and sometimes stability studies. 2. Exhibit Batches (also called Pilot Scale Batches) • Purpose: To generate data for regulatory submission (e.g., ANDA, NDA, or dossiers). • Stage: Made after lab-scale development but before full-scale production. • Key Focus: • Bridging between R&D and commercial scale • Supports bioequivalence (BE) studies and stability data • Demonstrates product performance at a scale closer to commercial • Scale: Usually at least 1/10th of the commercial batch size or as required by regulatory guidelines. • Used for: Bioequivalence studies, stability testing, and regulatory filing documentation. 3. Submission Batches • Purpose: Specific term used when batches are manufactured and tested for the actual data submission to regulatory authorities. • Stage: Can overlap with exhibit or validation batches, depending on context and regulatory requirements. • Key Focus: • Provide comprehensive data for dossier submission (e.g., formulation, manufacturing process, quality control, stability). • Used for: Regulatory dossier (CMC section), supporting approval of marketing authorization.

Why “3 Consecutive Batches” in Process Validation? 💊📊 It’s not a rigid regulatory rule—it’s scientific logic. ✔️ Batch 1: Confirms initial process performance ✔️ Batch 2: Checks repeatability (not a coincidence) ✔️ Batch 3: Demonstrates reproducibility & stability 🔬 Why three? • One success may be accidental • Two data points form a straight line (no variability insight) • Three batches give minimum statistical confidence in consistency 📘 Regulatory view: FDA, EMA, WHO, EU GMP recommend (not mandate) three batches as a baseline, with strong emphasis on risk-based justification. ⚠️ When more batches are needed: • New or complex technologies • Major process changes • Limited or poor historical data 🎯 Bottom line: Three batches balance science, risk management, and efficiency—the core of modern pharmaceutical quality systems.

Registration Batches (PPQ & Validation Batches)

Ensuring Regulatory Compliance for Market Approval

As drug products move toward commercialization, Process Performance Qualification (PPQ) and validation batches are essential for obtaining regulatory approval and ensuring readiness for the market. At MedPharm, we manufacture registration batches in GMP-certified facilities, ensuring that your drug product meets the highest standards of regulatory compliance, quality, and safety required for FDA, EMA, and ICH submissions.   

Our PPQ and validation batch programs help mitigate risks associated with commercial manufacturing by ensuring consistent, reproducible, and scalable production processes that meet critical quality attributes (CQAs) and regulatory expectations.   

Comprehensive Registration Batch Manufacturing Services

Process Performance Qualification (PPQ) Batches  

PPQ batches confirm that your manufacturing process consistently produces high-quality drug products that meet regulatory expectations.  

• GMP-compliant production of PPQ batches for NDA, BLA, ANDA, and MAA filings  

• Verification of process reproducibility across multiple commercial-scale batches  

• Alignment with FDA, EMA, and ICH process validation requirements  

• Comprehensive batch record documentation for regulatory filings 

Validation Batches for Commercial Launch  

Validation batches demonstrate that your commercial-scale production process meets predetermined quality criteria, ensuring consistent batch-to-batch reproducibility.  

• Validation of critical process parameters (CPPs) and critical quality attributes (CQAs)  

• ICH-compliant stability testing to confirm shelf-life and formulation integrity  

• Analytical method validation and real-time process monitoring  

• Full regulatory documentation support for marketing approval 

Regulatory & Quality Oversight  

MedPharm’s regulatory and quality teams work closely with clients to ensure that registration batches comply with:  

• FDA & EMA Guidelines for Process Validation  

• ICH Q8, Q9, and Q10 requirements for pharmaceutical development  

• cGMP requirements for commercial production  

• Global regulatory submission standards for NDA, BLA, ANDA, and MAA    

Seamless Transition from PPQ to Commercial Manufacturing  

Once PPQ and validation batches are successfully completed, MedPharm ensures a smooth transition to full-scale commercial manufacturing, providing:  

• Ongoing process monitoring and quality control  

• Batch-to-batch reproducibility and efficiency optimization  

• Scalability for global commercial supply 

Ensure Regulatory Success with MedPharm’s PPQ & Validation Batch Expertise

With decades of experience in clinical and commercial manufacturing, MedPharm ensures that your registration batches meet the highest standards for regulatory compliance, quality, and safety, helping you achieve market approval and commercial success.  

4 Types Process Validation in Pharmaceutical and Protocol

Imp: all : https://pharmaguddu.com/process-validation-pharmaceutical/ 

https://pharmaguidehub.com/blog/2024/01/22/process-validation/

https://www.youtube.com/watch?v=zQ-xjBtMcyE

https://pharmuni.com/2025/11/28/process-validation-in-pharmaceuticals-complete-guide-to-stages-requirements-documentation-year/